The Rheumatoid Arthritis Drugs Market Generated $12.7bn in 2010

Wednesday 31 August 2016, Amsterdam

Market Research Report Press Release A new report, now available on ASDReports, predicts that world revenues for rheumatoid arthritis drugs will rise strongly between 2011 and 2021. This market will grow to reach $17.3bn in 2015. The rheumatoid arthritis drugs market generated $12.7bn in 2010, according to Rheumatoid Arthritis: World Drug Market 2011-2021, published in September 2011.

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which skeletal joints become inflamed, causing pain, swelling and stiffness. RA can affect a person's ability to carry out everyday tasks. It is not known why rheumatoid arthritis develops, and there is no cure. Understanding of the disease has improved, however, and there are treatments that ease the pain and other symptoms, managing the disease.

Diya Lahiri, pharmaceutical industry analyst, said: "The world rheumatoid arthritis treatments market will benefit from the entry of new drugs this decade. There are prominent needs in the RA market, the most important being the development of drugs that are truly disease modifying rather than merely symptom managing. R&D efforts will help develop novel treatments that will not only benefit patients but also help researchers understand rheumatoid arthritis better."

 
Rheumatoid Arthritis (RA) Drugs Market 2016-2026

Rheumatoid Arthritis (RA) Drugs Market 2016-2026

Publish date : July 2016
Report code : ASDR-286694
Pages : 162

Rheumatoid Arthritis (RA) Drugs Market 2017-2027

Rheumatoid Arthritis (RA) Drugs Market 2017-2027

Publish date : November 2017
Report code : ASDR-428141
Pages : November 2017

ASDReports.com Media contact: S. Koopman - Marketing and Communications

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : stefan.koopman@asdreports.com

 back to News